Role of bile acid sequestrants in the treatment of type 2 diabetes - Wikidata - wikimedia - TriplyDB

Role of bile acid sequestrants in the treatment of type 2 diabetes

Role of bile acid sequestrants in the treatment of type 2 diabetes

http://www.wikidata.org/entity/Q28236411

about

Practical combination therapy based on pathophysiology of type 2 diabetes Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels Gut microbiota from twins discordant for obesity modulate metabolism in mice MPINet: metabolite pathway identification via coupling of global metabolite network structure and metabolomic profile.American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials.Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2 Treatment Approach to Patients With Severe Insulin Resistance.History of current non-insulin medications for diabetes mellitus.Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect.Mechanisms of current therapies for diabetes mellitus type 2 Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated.Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes.The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.Cardiometabolic impact of non-statin lipid lowering therapies.Application of clinical judgment and guidelines to achieving glycemic goals in type 2 diabetes: focus on pharmacologic therapy.Pharmacological treatment of diabetes in older people.The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.The Influence of Bariatric Surgery on Serum Bile Acids in Humans and Potential Metabolic and Hormonal Implications: a Systematic Review.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.

P2860

Q28076530-1893F726-3628-422D-80BD-F439B38BF334 Q28593904-06BB4C70-3A68-43D0-9D3F-7A19235DAD4C Q29614796-64D59A21-9DEA-41A6-B658-DE3C63FAF928 Q33892898-41FA16D4-7AFD-48E6-8665-6AA94C4AF822 Q34081331-043652BB-4CC4-463D-BD23-6D36AF6C6554 Q34475476-BDF97421-3B6A-4147-90D3-6E616E81351A Q35148954-0274C2D7-D01C-4386-92C8-7F240F17A2CB Q36803134-069FC1CB-EAA1-4ADA-8127-45595C781A70 Q37021310-160768F7-B14B-4E84-AA01-CEE4ED02B565 Q37034939-1D4A4AA1-712F-4EC8-BC5B-A325EC93AC81 Q37180829-B73172CD-D749-410C-9909-F926414CDD59 Q37509313-F627E9D3-9201-4728-9D33-2B2E4D646AC6 Q37664993-7657BA1A-077E-473F-8416-25E35C833ECD Q38115636-6814D6FC-FB41-413D-961E-E161DE6018C2 Q38128788-5848E700-166B-4D70-AC76-726EA708D95A Q38176275-244EA179-1DEE-4142-AB09-497BBC52C8C6 Q38219485-28080573-84E2-4749-B53B-1BD72F25F418 Q38235153-7CC58223-FC48-4107-982B-F1CFC7EFCCBE Q38474070-B213DE62-ACEB-4CFF-9443-DEFD7F8AC984 Q38579826-9AB3B269-11D3-4AE0-8CBF-60BF7759CF31 Q38839105-6F64B9E2-A9AD-46F3-85EB-2A81AD0416A6 Q38907817-F3A7F11A-6C52-4B86-BCA2-F716E2FE5B61 Q38925481-53000076-B8DC-4001-B7BB-4AFFE382DCD9 Q50075636-E5F2D7D3-685E-45BC-B745-CF13C79DECB4

P2860

Role of bile acid sequestrants in the treatment of type 2 diabetes

http://www.wikidata.org/entity/Q28236411

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Role of bile acid sequestrants in the treatment of type 2 diabetes

@ast

Role of bile acid sequestrants in the treatment of type 2 diabetes

@en

Role of bile acid sequestrants in the treatment of type 2 diabetes

@nl

type

label

Role of bile acid sequestrants in the treatment of type 2 diabetes

@ast

Role of bile acid sequestrants in the treatment of type 2 diabetes

@en

Role of bile acid sequestrants in the treatment of type 2 diabetes

@nl

prefLabel

Role of bile acid sequestrants in the treatment of type 2 diabetes

@ast

Role of bile acid sequestrants in the treatment of type 2 diabetes

@en

Role of bile acid sequestrants in the treatment of type 2 diabetes

@nl

P1433

Q28236411-5B426713-0B58-4FD6-9409-D323884D7C47

P1476

Q28236411-32474431-1ADF-4C87-A3F8-F3D557AB8692

P2093

Q28236411-823E6EBC-21CB-410A-B4AE-DC6757E4175A

P275

Q28236411-E1046193-1363-4168-85E5-3554B9E92C2D

P2860

Q28236411-087CB200-1DA1-493D-873C-80CDAE12D509

Q28236411-0C39C527-D179-488A-9A87-9DE21542A3F3

Q28236411-0C557FC8-93F0-4E61-8668-E1B95DEECBB7

Q28236411-12A48E14-0A9C-43E5-9ADA-6591AC3F1320

Q28236411-172803E7-54A7-450F-9F1A-D0FF5420A252

Q28236411-1D39AA99-9FE7-4612-AD66-FC86F22105BB

Q28236411-21439D66-B5B7-45B2-85D2-80779D702921

Q28236411-263AC3A8-8C5B-4CA9-9412-5F73F73DC179

Q28236411-2C43D58C-79EC-43A4-B74F-D384A8382C94

Q28236411-3B7F8A62-BB5A-41A0-8863-275E33CE8D95

P304

Q28236411-F17DEB2A-A6A0-4B9F-833B-CE2C85ACEF13

P31

Q28236411-0C86C237-DD9D-411A-9A70-9A9D284E4E90

Q28236411-EF529797-109E-4980-AC45-6F5BE56BB239

P3181

Q28236411-CB010982-0FCA-46E6-B414-D6A7A4A2504F

P356

Q28236411-09B3AC83-4315-4FDB-B9A1-B99B87139363

P407

Q28236411-E0367752-5703-469B-960C-36037F08DF77

P433

Q28236411-B371608C-7EB3-4CFB-88EE-24BA51B2B4FB

P478

Q28236411-FB48AF3F-B3AB-45EB-89B0-1065409E5AF8

P5008

Q28236411-745B9467-3E06-4CC2-9072-730626F8AF4B

P577

Q28236411-53AE61CF-B26D-4870-8C47-D8BB9AB1A323

Q28236411-FD406606-A229-4D3F-84AF-F143BFC96686

P5875

Q28236411-2C2738DC-DB00-4E53-A315-63219CD2FE14

P698

Q28236411-04E3078B-FDEB-4538-B3F5-4C6B56382621

P921

Q28236411-3897BDEC-A936-48E2-A371-C5DB05ABF087

Q28236411-467C06ED-B434-4441-A2E1-66E5ECA44944

Q28236411-AE821D51-D424-4B15-AD9F-F44FB7C770D1

P932

Q28236411-B4D493C2-FE06-4799-87E2-7AD3C0676C7F

P3181

P356

P1433

P1476

Role of bile acid sequestrants in the treatment of type 2 diabetes

@en

P2093

Yehuda Handelsman

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Standards of medical care in diabetes--2010.

The natural history of type 2 diabetes. Implications for clinical practice.

Safety considerations with gastrointestinally active lipid-lowering drugs.

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

P304

S244-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

498086

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DC11-S237

http://www.w3.org/2001/XMLSchema#string

P407

P433

Supplement_2

http://www.w3.org/2001/XMLSchema#string

P478

34 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51082122

http://www.w3.org/2001/XMLSchema#string

P698

21525463

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

mechanism of action

maturity-onset diabetes of the young

P932

3632187

http://www.w3.org/2001/XMLSchema#string